Cancer market commentary: 3 highlights from ESMO (Part 1)Commentary on key cancer data from ESMO by Stephanie Hawthorne Share XCancer market commentary: 3 highlights from ESMO (Part 1)https://pharmaphorum.com/esmo-2016/cancer-market-commentary-3-highlights-esmo-conference-part-1/